kabutan

Medical Data Vision, First Half Ordinary Profit Turns to Profit

Tue Aug 12, 2025 3:30 pm JST Earnings

3902 Medical Data Vision Co.,Ltd. 【J-GAAP】

Earnings Report

Medical Data Vision Co.,Ltd. <3902> [TSE Prime] announced its financial results after the market closed on August 12th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) turned into a profit of 3 million yen (compared to a loss of 32 million yen in the same period last year). However, Progress toward the full-year plan of 2500 million yen was 0.1%, also falling below the five-year average of 43.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the July to December period (second half) is expected to turn into a profit of 2497 million yen (compared to a loss of 477 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated ordinary loss improved to a deficit of 17 million yen (compared to a loss of 54 million yen in the same period last year). The operating profit/loss margin improved from -1.9% in the same period last year to -1.5%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 3,002 719 700 445 11.7 41.2 Aug 10, 2023 J-GAAP
Jan - Jun, 2024 2,780 26 -32 -86 -2.3 ー Aug 8, 2024 J-GAAP
Jan - Jun, 2025 3,034 -5 3 -10 -0.3 0.1 Aug 12, 2025 J-GAAP
YoY +9.1% － － +88.4% +88.1%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 10, 2025 J-GAAP
Jan - Jun, 2025 Results 3,034 -5 3 -10 -0.3 0 Aug 12, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 3,126 -23 -477 -705 -18.5 6.50 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 5,966 2,605 2,497 1,660 43.9 9 Aug 12, 2025 J-GAAP
YoY +90.9% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 6,419 1,770 1,700 979 25.6 6.50 Feb 13, 2024 J-GAAP
Dec, 2024 5,906 3 -509 -791 -20.7 6.50 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 9,000 2,600 2,500 1,650 43.6 9 Feb 10, 2025 J-GAAP
YoY +52.4% +86,566.7% － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 1,392 -27 -54 -71 -1.9 -1.9 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 1,345 -166 -197 -228 -6.0 -12.3 Nov 11, 2024 J-GAAP
Oct - Dec, 2024 1,781 143 -280 -477 -12.5 8.0 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 1,532 17 20 12 0.3 1.1 May 12, 2025 J-GAAP
Apr - Jun, 2025 1,502 -22 -17 -22 -0.6 -1.5 Aug 12, 2025 J-GAAP
YoY +7.9% +18.5% +68.5% +69.0% +68.4%

Related Articles